FDA Panel Warns Against Certain Back Pain Injections
Written by Editor   
Wednesday, December 10, 2014 01:51 PM

Epidural steroid injections (ESIs) should be contraindicated under certain circumstances in the management of back pain, the US Food and Drug Administration's (FDA's) Anesthetic and Analgesic Drug Products Advisory Committee has concluded.

After 2 days of presentations and discussions, committee members agreed that injecting a particulate steroid in the cervical region, using the transforaminal approach, increases the risk for sometimes serious and irreversible neurological adverse events, including stroke, paraplegia, spinal cord infarction, and even death.

At the end of the meeting, committee members voted 15 to 7 that there are clinical situations for which a contraindication to ESIs are warranted (there was a single abstention).

Source:  http://www.medscape.com/viewarticle/835613